Summary

Middle East Animal Health Market Summary

The Middle East animal health market size was estimated at USD 1.23 billion in 2024 and is projected to reach USD 2.70 billion by 2033, growing at a CAGR of 9.14% from 2025 to 2033. The animal health market in the Middle East is continuously growing, driven by rising livestock demand and food security initiatives, increasing pet ownership and companion animal care, and expansion of veterinary infrastructure and services.

The region relies heavily on livestock for meat, milk, and other animal-based products due to cultural dietary preferences and limited arable land. According to the report of March 2025, Al-Ra’i National Livestock Company, a NADEC subsidiary, secured a USD 293.2 million loan from Saudi Arabia’s Agricultural Development Fund to enhance red meat production. The project will expand sheep and goat farming, aiming for an annual output of one million livestock.

To reduce dependency on imports and ensure food security, governments in the region are investing in animal husbandry and health infrastructure. In January 2025, Oman is expecting to boost regional veterinary capacity with a RO15mn animal vaccine facility in Khazaen, aiming to produce 2 billion doses annually, enhance food security, and strengthen biosecurity. This initiative aims to boost regional veterinary care and position Abu Dhabi as a key hub for innovative animal healthcare and vaccine production across the Middle East and Africa. In addition, in July 2025, Qatar’s Animal Wealth Department and Belarusian veterinary experts held talks to explore collaboration in developing local animal health capabilities, focusing on advancing veterinary services and livestock sector growth.

Due to increasing urbanization and rising disposable incomes, there has been a noticeable surge in pet ownership across Middle Eastern countries, particularly in the UAE, Saudi Arabia, and Qatar. Changing social attitudes have led to more households adopting dogs, cats, and exotic animals, creating a burgeoning demand for companion animal healthcare. Pet parents are increasingly spending on vaccinations, routine check-ups, grooming, pet insurance, and preventive treatments. Veterinary clinics and pet hospitals are expanding, and online platforms offering pet care products and tele-veterinary services are growing in popularity.The launch of Saudi Arabia’s first pet insurance platform in 2024 and Paws & Partners Forum represent a transformative step in the companion animal health market. By making veterinary care more affordable and accessible, pet insurance is expected to drive increased visits to animal clinics, greater uptake of preventive care, and demand for specialized services.

The Middle East is witnessing the rapid development of veterinary infrastructure, driven by both government support and private sector participation. Veterinary hospitals, mobile clinics, diagnostic labs, and research centers are expanding in number and capabilities. Along with this, in February 2021, Biogal partnered with the UAE's Eurovets following the Israel-UAE peace treaty, marking a historic collaboration to enhance animal welfare through advanced veterinary diagnostics and solutions. These expansions and collaborations improve access to quality care, diagnostics, and medicines, particularly in urban and semi-urban areas, and are playing a key role in shaping a more sophisticated and well-regulated animal health ecosystem across the region.

Middle East Animal Health Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the Middle East animal health market report based on product, animal, distribution channel, end use, and country:

• Animal Outlook (Revenue, USD Million, 2021 - 2033)
• Production Animals
o Poultry
o Cattle
o Sheep & Goats
o Fish
• Companion Animals
o Dogs
o Cats
o Horses
o Pet Birds
o Others
• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Biologics
o Vaccines
o Modified/ Attenuated Live
o Inactivated (Killed)
o Other Vaccines
o Other Biologics
• Pharmaceuticals
o Parasiticides
o Anti-infectives
o Anti-inflammatory
o Analgesics
o Others
• Medicated Feed Additives
• Diagnostics
o Consumables, reagents and kits
o Instruments and devices
• Equipment & Disposables
o Critical Care Consumables
o Anesthesia Equipment
o Fluid Management Equipment
o Temperature Management Equipment
o Rescue & Resuscitation Equipment
o Research Equipment
o Patient Monitoring Equipment
• Others
o Veterinary Telehealth
o Veterinary Software
o Livestock Monitoring
• Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
• Retail
• E-Commerce
• Hospital/ Clinic Pharmacy
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Veterinary Reference Laboratories
• Point-of-care Testing/In-house Testing
• Veterinary Hospitals & Clinics
• Others
• Country Outlook (Revenue, USD Million, 2021 - 2033)
• UAE
• Saudi Arabia
• Kuwait
• Qatar
• Oman

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Sources
1.3.4. Primary Research
1.3.5. Details of Primary Research
1.3.6. Data analysis model
1.4. Information/Data Analysis
1.5. Market Formulation & Visualization
1.6. Data Validation & Publishing
1.7. Model Details
1.7.1. Commodity flow analysis
1.7.2. Volume price analysis
1.8. List of Secondary Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Middle East Animal Health Market Variable Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market
3.1.2. Ancillary Market
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising livestock demand and food security initiatives
3.2.1.2. Growth in pet ownership and companion animal care
3.2.1.3. Expansion of veterinary infrastructure and services
3.2.2. Market Restraint Analysis
3.2.2.1. Limited access to skilled professionals
3.2.3. Market Opportunity Analysis
3.2.4. Market Challenge Analysis
3.3. Middle East Animal Health Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitution
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Legal landscape
3.3.2.3. Economic landscape
3.3.2.4. Social landscape
3.3.2.5. Technological landscape
3.3.2.6. Environmental landscape
3.3.3. Regulatory Framework
3.3.4. Estimated Animal Population, key species, 2024
Chapter 4. Middle East Animal Health Market: Animal Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Middle East Animal Health Market: Animal, market share 2024 & 2033
4.3. Middle East Animal Health Market Size & Trend Analysis, by animal, 2021 to 2033 (USD Million)
4.4. Production Animals
4.4.1. Production Animals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.2. Poultry
4.4.2.1. Poultry Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.3. Cattle
4.4.3.1. Cattle Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.4. Sheep & Goats
4.4.4.1. Sheep & Goats Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.5. Fish
4.4.5.1. Fish Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5. Companion animals
4.5.1. Companion Animals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.2. Dogs
4.5.2.1. Dogs Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.3. Cats
4.5.3.1. Cats Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.4. Horses
4.5.4.1. Horses Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.5. Pet birds
4.5.5.1. Pet birds Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.6. Others
4.5.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. Middle East Animal Health Market: Distribution Channel Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Middle East Animal Health Market: Distribution Channel, market share 2024 & 2033
5.3. Middle East Animal Health Market Size & Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
5.4. Retail
5.4.1. Retail Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5. E-Commerce
5.5.1. E-Commerce Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6. Hospital/ Clinic Pharmacy
5.6.1. Hospital/ Clinic Pharmacy Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. Middle East Animal Health Market: Product Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Middle East Animal Health Market: Product, market share 2024 & 2033
6.3. Middle East Animal Health Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
6.4. Biologics
6.4.1. Biologics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.2. Vaccines
6.4.2.1. Vaccines Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.2.1.1. Modified/ Attenuated Live
6.4.2.1.1.1. Modified/ Attenuated Live Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.2.1.2. Inactivated (Killed)
6.4.2.1.2.1. Inactivated (Killed) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.2.1.3. Other Vaccines
6.4.2.1.3.1. Other Vaccines Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.3. Other Biologics
6.4.3.1. Other Biologics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5. Pharmaceuticals
6.5.1. Pharmaceuticals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.2. Parasiticides
6.5.2.1. Parasiticides Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.3. Anti-infectives
6.5.3.1. Anti-infectives Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.4. Anti-inflammatory
6.5.4.1. Anti-inflammatory Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.5. Analgesics
6.5.5.1. Analgesics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.6. Others
6.5.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. Medicated Feed Additives
6.6.1. Medicated Feed Additives Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7. Diagnostics
6.7.1. Diagnostics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7.2. Consumables, reagents and kits
6.7.2.1. Consumables, reagents and kits Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7.3. Instruments and devices
6.7.3.1. Instruments and devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8. Equipment & Disposables
6.8.1. Equipment & Disposables Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8.2. Critical Care Consumables
6.8.2.1. Critical Care Consumables Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8.3. Anesthesia Equipment
6.8.3.1. Anesthesia Equipment Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8.4. Fluid Management Equipment
6.8.4.1. Fluid Management Equipment Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8.5. Temperature Management Equipment
6.8.5.1. Temperature Management Equipment Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8.6. Rescue & Resuscitation Equipment
6.8.6.1. Rescue & Resuscitation Equipment Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8.7. Research Equipment
6.8.7.1. Research Equipment Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8.8. Patient Monitoring Equipment
6.8.8.1. Patient Monitoring Equipment Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.9. Others
6.9.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.9.2. Veterinary Telehealth
6.9.2.1. Veterinary Telehealth Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.9.3. Veterinary Software
6.9.3.1. Veterinary Software Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.9.4. Livestock Monitoring
6.9.4.1. Livestock Monitoring Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Middle East Animal Health Market: End Use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Middle East Animal Health Market: By End Use, market share 2024 & 2033
7.3. Middle East Animal Health Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
7.3.1. Veterinary Reference Laboratories
7.3.1.1. Veterinary Reference Laboratories Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.3.2. Point-of-care Testing/In-house Testing
7.3.2.1. Point-of-care Testing/In-house Testing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.3.3. Veterinary Hospitals & Clinics
7.3.3.1. Veterinary Hospitals & Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.3.4. Others
7.3.4.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 8. Middle East Animal Health Market: Country Estimates & Trend Analysis
8.1. Country Dashboard
8.2. Middle East Animal Health Market Share, By Region, 2024 & 2033, USD Million
8.3. Country Outlook
8.4. UAE
8.4.1. UAE Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5. Saudi Arabia
8.5.1. Saudi Arabia Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
8.6. Kuwait
8.6.1. Kuwait Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
8.7. Qatar
8.7.1. Qatar Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
8.8. Oman
8.8.1. Oman Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 9. Competitive Landscape
9.1. Market Participant Categorization
9.2. Company Market Position Analysis/ Heat Map Analysis
9.3. Company Profiles
9.3.1. Boehringer Ingelheim International GmbH
9.3.1.1. Participant’s Overview
9.3.1.2. Financial Performance
9.3.1.3. Product Benchmarking
9.3.1.4. Strategic Initiatives
9.3.2. Zoetis Services LLC
9.3.2.1. Participant’s Overview
9.3.2.2. Financial Performance
9.3.2.3. Product Benchmarking
9.3.2.4. Strategic Initiatives
9.3.3. Virbac
9.3.3.1. Participant’s Overview
9.3.3.2. Financial Performance
9.3.3.3. Product Benchmarking
9.3.3.4. Strategic Initiatives
9.3.4. Merck & Co., Inc.
9.3.4.1. Participant’s Overview
9.3.4.2. Financial Performance
9.3.4.3. Product Benchmarking
9.3.4.4. Strategic Initiatives
9.3.5. Elanco
9.3.5.1. Participant’s Overview
9.3.5.2. Financial Performance
9.3.5.3. Product Benchmarking
9.3.5.4. Strategic Initiatives
9.3.6. Ceva Santé Animale
9.3.6.1. Participant’s Overview
9.3.6.2. Financial Performance
9.3.6.3. Product Benchmarking
9.3.6.4. Strategic Initiatives
9.3.7. Biovac
9.3.7.1. Participant’s Overview
9.3.7.2. Financial Performance
9.3.7.3. Product Benchmarking
9.3.7.4. Strategic Initiatives
9.3.8. Hipra
9.3.8.1. Participant’s Overview
9.3.8.2. Financial Performance
9.3.8.3. Product Benchmarking
9.3.8.4. Strategic Initiatives
9.3.9. Hester Biosciences
9.3.9.1. Participant’s Overview
9.3.9.2. Financial Performance
9.3.9.3. Product Benchmarking
9.3.9.4. Strategic Initiatives
9.3.10. Biogenesis Bago
9.3.10.1. Participant’s Overview
9.3.10.2. Financial Performance
9.3.10.3. Product Benchmarking
9.3.10.4. Strategic Initiatives
9.3.11. Nutreco
9.3.11.1. Participant’s Overview
9.3.11.2. Financial Performance
9.3.11.3. Product Benchmarking
9.3.11.4. Strategic Initiatives
9.3.12. Julphar
9.3.12.1. Participant’s Overview
9.3.12.2. Financial Performance
9.3.12.3. Product Benchmarking
9.3.12.4. Strategic Initiatives
9.3.13. Al-AHD Veterinary Company
9.3.13.1. Participant’s Overview
9.3.13.2. Financial Performance
9.3.13.3. Product Benchmarking
9.3.13.4. Strategic Initiatives
9.3.14. Animal Nation KSA LTD
9.3.14.1. Participant’s Overview
9.3.14.2. Financial Performance
9.3.14.3. Product Benchmarking
9.3.14.4. Strategic Initiatives
9.4. Strategy Mapping
9.4.1. Mergers & Acquisitions
9.4.2. Partnerships & Collaborations
9.4.3. Product launch
9.4.4. Others
9.5. List of other key players